Neurology Grand Rounds: Donanemab, and Other Updates to Anti-Amyloid Therapy, for the Treatment of Early Alzheimer’s disease

Andrew Natonson, M.D., M.S., Assistant Professor, Neurology Residency Program Director, Director Alzheimer’s Amyloid Clinic, Division of Aging, Alzheimer’s and Related Disorders & Division of Comprehensive Neurology, Department of Neurology, OHSU

When
Wednesday, February 5, 2025
8 to 9 a.m. PST
Where
3245 SW Pavilion Loop
Portland, Oregon 97239
4248
Contact Information

Virtual

View the live stream, or join us through our Webex meeting link, starting at 7:50 a.m. Wednesday

  • Live streamstream the meeting
  • Webex meetinguse this link if you plan to participate in the Q & A session. Ask your questions in the chat window.